China Biologic Receives Operating Permit for New Branch Collection Facility in Shandong Province China

China Biologic Products, Inc. CBPO today announced that, on October 19, 2015, the Company's majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd. ("Shandong Taibang"), received the operating permit from local authorities to commence plasma collection at the new branch collection facility in Zaozhuang City, Shandong Province. As previously announced, Shandong Taibang received approval to build this new branch collection facility in September 2015. This new branch collection facility will operate under the Company's Ningyang plasma collection station and cover the collection territory of Zaozhuang City, which has a population of 3.8 million and offers a reliable source of plasma donors. The Company expects to commence operation and trial collection of source plasma at this new branch collection facility immediately and achieve its designed annual collection capacity within three years thereafter. Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, "We are pleased to receive the operating permit and be able to launch trial operation at our new branch collection facility in Shandong Province. Together with the other eight plasma collection stations in Shandong Province, this new facility See full press release